OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Different Disease Pathways to Idiopathic Parkinson’s Disease: Three Genetically-Defined Subgroups with Different Treatment Responses in Phase III Disease-Modifying Trials and Distinct Clinical Trajectories
Antony is a cell & molecular biologist and geneticist with strong research interests into the causative mechanism(s) of Parkinson’s Disease, and therapeutic approaches to successfully treat PD patients, especially with respect to slowing disease progression in idiopathic patients.
Recently in his role as the Research Director of the Australian Parkinson’s Mission, Antony and his collaborators have made substantial progress in identifying three genetically-defined subgroups of idiopathic patients whose analysis supports three differing disease mechanisms.
Date:
23 June 2025, 12:00
Venue:
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
Venue Details:
This seminar will be held in the Dorothy Crowfoot Hodgkin Building, Ground Floor Seminar Room (20-138). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker:
Associate Professor Antony Cooper (Garvan Institute of Medical Research, Australia)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Lorraine Dyson (University of Oxford)
Host:
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of:
OPDC Seminar Series (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Lorraine Dyson
